A pilot study of lymphodepletion intensity for PBMC-derived, neoantigen-specific CD8+ T cells (Neo-Ts) therapy in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results